Structural Heart Imaging Market Overview
As per MRFR analysis, the Structural Heart Imaging Market Size was estimated at 18.72 (USD Billion) in 2022. The Structural Heart Imaging Market Industry is expected to grow from 20.34(USD Billion) in 2023 to 42.9 (USD Billion) by 2032. The Structural Heart Imaging Market CAGR (growth rate) is expected to be around 8.64% during the forecast period (2024 - 2032).
Key Structural Heart Imaging Market Trends Highlighted
The Structural Heart Imaging Market appears to be on an upward trajectory, which is attributed to the increasing occurrence of structural heart illnesses and the rising use of innovative imaging modalities. Market growth factors include an increase in the need for less invasive procedures, innovations in catheter-based methods, and better early detection awareness.
Market prospects include the application of AI and ML technologies for enhancing image quality and interpretation, the creation of compact and easy-to-use devices for imaging at the site of need, and penetration to developing regions with the need for such services. Recent trends have seen the birth of integrated imaging products, the creation of specialized systems for image enhancement and analysis, and more frequent applications of 3D printing for customized therapeutic planning.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Structural Heart Imaging Market Drivers
Technological advancements in structural heart imaging devices
There has been advancement in imaging technology, and this trend has continued over the years. Structural heart imaging has been no exception for such kind of improvement. The imaging technology is now more sophisticated and accurate than ever before. For structural heart imaging, the advancement has been in the image resolution, visualization, and processing of data obtained from imaging. For example, the innovations that have been realized in recent times in transcatheter aortic valve implantation and mitral valve repair procedures have raised patient outcomes and decreased complications risk.
Advanced imaging, therefore, will continue to be a demand by health practitioners as it achieves greater adoption, hereby driving the market growth over the forecast period. The Structural Heart Imaging Market Industry will have significant growth in the sector as imaging technology advances are being adopted.
Rising prevalence of cardiovascular diseases
The growing prevalence of cardiovascular diseases, such as valvular heart disease and congenital heart defects, is one of the prominent factors propelling the expansion of the structural heart imaging market. As the aging of the global population is expected to increase the incidence of cardiovascular diseases, the need for improved diagnosis and timely monitoring is likely to rise. Structural heart imaging is essential and useful for the evaluation and treatment of these diseases as it provides a clear picture of the anatomy and function of the heart. The increasing demand for such examinations and procedures is expected to boost the expansion of the market during the forecast period.
Expanding applications in various clinical settings
Structural heart imaging is increasingly being used in a wider range of clinical settings beyond its traditional role in the diagnosis and management of valvular heart disease. For instance, it is now being used in the assessment of patients with heart failure, arrhythmias, and other cardiovascular conditions. This expansion of applications is driven by the ability of structural heart imaging to provide detailed anatomical and functional information, guiding treatment decisions and improving patient outcomes. The growing adoption of structural heart imaging in various clinical settings is expected to contribute to market growth over the forecast period.
Structural Heart Imaging Market Segment Insights
Structural Heart Imaging Market Procedure Type Insights
Procedure Type segments the Structural Heart Imaging Market into Transcatheter Aortic Valve Implantation, Transcatheter Mitral Valve Replacement, Transcatheter Tricuspid Valve Replacement, Left Atrial Appendage Closure, and Patent Foramen Ovale Closure. TAVI is the most common structural heart imaging procedure, accounting for over 50% of the global market revenue in 2023. The increasing prevalence of aortic stenosis is driving the growth of the TAVI market. TMVR is the second-largest segment, with a market share of over 25% in 2023.
The growing number of patients with mitral regurgitation is contributing to the growth of the TMVR market. TTVR is a relatively new procedure, but it is expected to grow rapidly in the coming years due to the increasing prevalence of tricuspid regurgitation. The growth of the market is attributed to the increasing prevalence of cardiovascular diseases, the growing demand for minimally invasive procedures, and the technological advancements in structural heart imaging devices.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Structural Heart Imaging Market Imaging Modality Insights
The Imaging Modality segment of the Structural Heart Imaging Market is estimated to expand significantly over the forthcoming years. The segment will be primarily supported by the rising prevalence of cardiovascular diseases and the increasing uptake of sophisticated imaging modalities. Segment-wise, Transesophageal Echocardiography retained dominance over the market in 2023 and is anticipated to continue to lead the market throughout the forecast period. The imaging modality offers high-resolution images of the heart and its structures in real-time, which makes it ideal for the assessment and monitoring of structural heart diseases.
Intravascular Ultrasound is another key imaging modality used in structural heart imaging. The imaging modality is primarily used for determining the intensity of peripheral artery disease and providing guidance in the raction therapy for the correction of suboptimal stent placement. Fluoroscopy, Cardiac Magnetic Resonance Imaging, and Computed Tomography are the other imaging modalities used for structural heart imaging, along with their key application areas. In 2023, the Structural Heart Imaging Market was estimated at USD 20.34 billion and is anticipated to expand at a CAGR of 8.645 by 2032 and attain USD 42.9 billion by 2032.
Structural Heart Imaging Market Vendor Type Insights
The Structural Heart Imaging Market is expected to witness significant growth in the upcoming years. Market segmentation plays a crucial role in understanding the dynamics of the industry. One key segment is Vendor Type, which categorizes market players based on their business models. Major players in the Structural Heart Imaging Market can be Original Equipment Manufacturers (OEMs) and Third-Party Vendors. OEMs are involved in the design, development, and production of structural heart imaging devices. They have a strong brand presence and established distribution channels, allowing them to capture a significant share of the market.
Third-party vendors, on the other hand, focus on providing specialized components, services, or accessories for structural heart imaging systems. They often collaborate with OEMs to enhance device functionality or offer complementary solutions. The growth is attributed to the rising prevalence of cardiovascular diseases, technological advancements, and increasing healthcare expenditure.
Structural Heart Imaging Market Application Insights
The Structural Heart Imaging Market Segmentation by Application includes Diagnostic Imaging and Therapeutic Interventions. The diagnostic Imaging segment held a market share of around 84% in 2023 and is expected to continue dominating in the years to come, primarily driven by the rising prevalence of cardiovascular diseases and the increasing adoption of advanced imaging techniques. Therapeutic Interventions segment, on the other hand, is anticipated to exhibit a faster growth rate during the forecast period owing to the growing adoption of minimally invasive procedures for the treatment of cardiovascular diseases.
Structural Heart Imaging Market End User Insights
The end user segment of the Structural Heart Imaging Market is categorized into hospitals, cardiac centers, ambulatory surgery centers, and clinics. Each segment holds a specific market share and contributes to the overall growth of the industry. Hospitals account for a significant portion of the Structural Heart Imaging Market revenue due to their comprehensive healthcare services and advanced imaging capabilities. The presence of specialized cardiac units and experienced medical professionals makes hospitals a preferred destination for patients seeking structural heart imaging procedures.
Cardiac centers, dedicated to the diagnosis and treatment of heart conditions, also hold a notable market share. These centers offer specialized imaging equipment and expertise in performing complex structural heart imaging procedures. Their focus on cardiac care attracts patients seeking advanced diagnostic and therapeutic options. Ambulatory surgery centers, which provide outpatient surgical procedures, are gaining popularity for structural heart imaging. The convenience and cost-effectiveness of these centers appeal to patients seeking minimally invasive procedures.
Clinics, including private practices and specialty clinics, contribute to the market by offering accessible and convenient structural heart imaging services. They often provide routine imaging examinations and refer patients to hospitals or cardiac centers for more complex procedures. The Structural Heart Imaging Market is driven by factors such as the increasing prevalence of cardiovascular diseases, technological advancements in imaging techniques, and growing awareness about the benefits of early diagnosis and intervention. These factors are expected to continue fueling market growth in the coming years.
Structural Heart Imaging Market Regional Insights
The Structural Heart Imaging Market is segmented by region into North America, Europe, APAC, South America, and MEA. North America is the largest regional market, accounting for a significant share of the global revenue. The region's high adoption of advanced medical technologies, well-established healthcare infrastructure, and presence of key market players contribute to its dominance. Europe holds the second-largest market share due to government initiatives promoting healthcare expenditure, increasing awareness of cardiovascular diseases, and a growing geriatric population.
APAC is projected to witness the fastest growth over the forecast period, driven by rising disposable income, increasing healthcare spending, and government efforts to improve healthcare access in emerging economies. South America and MEA represent smaller market shares but offer growth potential due to expanding healthcare infrastructure and increasing demand for advanced medical imaging solutions.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Structural Heart Imaging Market Key Players And Competitive Insights:
Major players in the Structural Heart Imaging Market industry are developing and marketing innovative products to expand their market presence. Leading Structural Heart Imaging Market players are focusing on collaborations and partnerships to strengthen their product offerings and expand their geographic reach. The Structural Heart Imaging Market is highly competitive, with a number of major players vying for market share. These players are constantly innovating and developing new products and technologies to gain an edge over their competitors. The competitive landscape in the Structural Heart Imaging Market is expected to remain intense in the coming years as major players continue to invest heavily in research and development.
One of the leading companies in the Structural Heart Imaging Market is Boston Scientific. Boston Scientific is a global leader in the development and manufacture of medical devices. The company offers a wide range of products for structural heart imaging, including catheters, guidewires, and imaging systems. Boston Scientific is committed to innovation and has a strong track record of developing new and improved products. The company is also actively involved in clinical trials and research to further develop its product offerings.
Another major player in the Structural Heart Imaging Market is Medtronic. Medtronic is a leading provider of medical technology and services. The company offers a broad range of products and services for structural heart imaging, including catheters, guidewires, and imaging systems. Medtronic is committed to developing innovative technologies and providing high-quality products and services to its customers. The company is also actively involved in clinical trials and research to further develop its product offerings and services.
Key Companies in the Structural Heart Imaging Market Include:
Structural Heart Imaging Market Industry Developments
The Structural Heart Imaging Market is expected to reach USD 42.9 billion by 2032, exhibiting a CAGR of 8.64% during the forecast period. Technological advancements, the rising prevalence of cardiovascular diseases, and the increasing adoption of minimally invasive procedures are driving market growth. Recent developments include the launch of new imaging systems with enhanced capabilities, such as the ACIST CVI system from Siemens Healthineers and the Artis icono biplane system from Philips Healthcare. Key market players are focusing on expanding their product portfolios and geographical presence through strategic partnerships and acquisitions. For instance, in 2023, Boston Scientific acquired Baylis Medical to strengthen its structural heart portfolio.
Structural Heart Imaging Market Segmentation Insights
-
Structural Heart Imaging Market Procedure Type Outlook
-
Transcatheter Aortic Valve Implantation (TAVI)
-
Transcatheter Mitral Valve Replacement (TMVR)
-
Transcatheter Tricuspid Valve Replacement (TTVR)
-
Left Atrial Appendage Closure (LAAC)
-
Patent Foramen Ovale (PFO) Closure
-
Structural Heart Imaging Market Imaging Modality Outlook
-
Transesophageal Echocardiography (TEE)
-
Intravascular Ultrasound (IVUS)
-
Fluoroscopy
-
Cardiac Magnetic Resonance Imaging (CMR)
-
Computed Tomography (CT)
-
Structural Heart Imaging Market Vendor Type Outlook
-
Structural Heart Imaging Market Application Outlook
-
Structural Heart Imaging Market End User Outlook
-
Structural Heart Imaging Market Regional Outlook
-
North America
-
Europe
-
South America
-
Asia-Pacific
-
Middle East and Africa
| Report Attribute/Metric |
Details |
| Market Size 2022 |
18.72(USD Billion) |
| Market Size 2023 |
20.34(USD Billion) |
| Market Size 2032 |
42.9(USD Billion) |
| Compound Annual Growth Rate (CAGR) |
8.64% (2024 - 2032) |
| Report Coverage |
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Base Year |
2023 |
| Market Forecast Period |
2024 - 2032 |
| Historical Data |
2019 - 2023 |
| Market Forecast Units |
USD Billion |
| Key Companies Profiled |
Medtronic, GE Healthcare, Esaote SpA, Canon Medical Systems, Hitachi Medical Corporation, Samsung Electronics, Boston Scientific, Terumo Corporation, Shimadzu Corporation, Fujifilm Holdings Corporation, Abbott Laboratories, Siemens Healthineers, Philips Healthcare, Johnson Johnson, Koninklijke Philips |
| Segments Covered |
Procedure Type, Imaging Modality, Vendor Type, Application, End User, Regional |
| Key Market Opportunities |
Growing prevalence of valvular heart diseases Technological advancements Expanding geriatric population Increasing healthcare expenditure Rising adoption of minimally invasive procedures. |
| Key Market Dynamics |
Increased prevalence of cardiovascular diseases Technological advancements Growing adoption of minimally invasive procedures Reimbursement policies Availability of skilled professionals |
| Countries Covered |
North America, Europe, APAC, South America, MEA |
Frequently Asked Questions (FAQ) :
The Structural Heart Imaging Market is expected to reach USD 42.9 billion by 2032, exhibiting a CAGR of 8.64% from 2024 to 2032.
The increasing prevalence of cardiovascular diseases, technological advancements, and growing adoption of minimally invasive procedures are the primary drivers of market growth.
North America is expected to dominate the global market throughout the forecast period due to the high prevalence of cardiovascular diseases, advanced healthcare infrastructure, and favorable reimbursement policies.
Structural Heart Imaging is primarily used for the diagnosis and management of valvular heart diseases, congenital heart defects, and cardiomyopathies.
Major players in the market include Abbott, Boston Scientific, Edwards Lifesciences, Medtronic, and Siemens Healthineers.
The Asia-Pacific region is anticipated to witness a significant growth rate of 9.5% during the forecast period, driven by rising healthcare expenditure and increasing awareness about cardiovascular diseases.
Technological advancements, such as the development of 3D echocardiography and intracardiac echocardiography, are enhancing the accuracy and precision of structural heart imaging, leading to improved patient outcomes.
Challenges include the high cost of procedures, limited reimbursement, and the need for specialized expertise, which may hinder the widespread adoption of structural heart imaging.
Growth opportunities lie in the development of novel imaging technologies, expansion into emerging markets, and increasing collaboration between healthcare providers and manufacturers.
Regulatory approvals and guidelines play a crucial role in shaping the market ensuring the safety and efficacy of structural heart imaging devices and procedures.
